A new coronavirus, similar in some ways to the SARS virus that arose a decade ago, appeared in the Middle East late in 2012 and is responsible for at least 13 human cases in 3 clusters, according to Gwen Stephens of the Saudi Arabia Ministry of Health in Riyadh, Saudi Arabia. She was one of several participants in a late-breaker symposium, "Emergence of a New Pathogenic Coronavirus: Are We Witnessing the Beginning of Another SARS-Like Pandemic, or Not?" during the 11th ASM Biodefense and Emerging Diseases Research Meeting, held last February in Washington, D.C. Their account portrays how quickly microbiologists, infectious disease specialists, and other experts responded to this outbreak involving a suspiciouslooking pathogen-identifying it, establishing a sense of its range and virulence, and setting up systems to detect and study it.
"We don't know if we're seeing the tip of the iceberg, or we're making a mountain out of a molehill," says another symposium participant, Alison Bermingham of the Microbiology Reference Services in the Health Protection Agency in London, United Kingdom (UK). The fırst in a cluster of three infected individuals in the UK who traveled there from Qatar was fatally ill. However, the third such case, a female, developed mild symptoms, and her infection proved self-limiting, Bermingham says. That experience raises questions about the case defınition and about the transmissibility of the virus.
The SARS virus emerged in 2002 (see p. 205), was initially misdiagnosed as influenza, circulated globally to cause about 900 deaths among some 8,000 human cases, and then came under control to do little, if any, further damage, Stephens says. The newer coronavirus proves virulent and deadly in most human cases so far, causing acute pneumonia with fever as well as kidney failure in some infected individuals. However, it does not appear to be readily transmitted, including from infected individuals to close family members or health care workers who contact those patients, she says. "It's a mystery why we haven't seen secondary cases associated with this novel coronavirus."
Remarkably, from a clinical microbiology standpoint, Bermingham and her local collaborators as well as others in the Netherlands and Germany very quickly determined that the coronavirus was novel, not another outbreak of SARS, and also worked out an assay for testing for it. "This assay was rolled out within two weeks to seven labs across the UK, [enabling them] to offer screening to returning visitors from the [Mideast] ," she says.
While several groups were responding to the new virus in Europe and the Mideast, Vincent Munster of the Rocky Mountain Laboratory of the National Institute of Allergy and Infectious Diseases in Hamilton, Mont., and his collaborators began testing what animal species the novel virus might infect. Because it failed to infect rodents, he and his collaborators quickly shifted to and succeeded in infecting macaques, where the virus causes "mild to moderate" symptoms but appears to remain within the respiratory system, he says. Even though the infection in macaques may not precisely parallel what happens in humans, it provides a source for producing the virus and evaluating some of its behavior-all within a few months of its fırst detection.
In The new gel is made from two polymers that, when mixed with water and heated, form a moldable gel that can be applied to the skin and resists being flushed away. "This antimicrobial hydrogel can be used to treat superfıcial wound infections or to remove superbugs, such as methicillin-resistant Staphylococcus aureus (MRSA)," Yang says. "It may also be used as a coating for implanted medical devices. Other possible applications include disinfectants, detergent, wet wipes, and hand wash to eliminate and prevent superbug infections. It may also be used in toothpaste, shampoo, cosmetics, and deodorant." The cost of the hydrogel would be comparable to that of conventional antibiotic creams, he points out.
When tested in vitro and applied once during 24 h to MRSA biofılms, more than 60% of the fılm's biomass was removed and more than 80% of the MRSA cells were eliminated, according to Yang. When applied onto animal skin, the hydrogel proves "biocompatible," he continues. In such tests, the topically applied hydrogel can overcome infections caused by a variety of microbial pathogens, including bacteria such as MRSA and Escherichia coli as well as Candida albicans fungi.
"It is amazing that this hydrogel completely inhibits growth and showed a nearly perfect killing effı-ciency on all microbial cells tested," says environmental microbiologist Xiaozhou Zhang at Gate Fuels Inc., in Blacksburg, Va. "The hydrogel is not only effective on free cells but also disrupts biofılms very effıciently." Another plus is the interdisciplinary nature of this undertaking, something he calls "a perfect combination of biological, chemical, and biomedical research." However, he cautions, the mechanisms by which the gels disrupt cell walls and membranes "need to be further addressed."
Positively charged components of the hydrogel interact initially with anionic surface components of the bacterial cell wall and membrane, according to Yang. Subsequently, hydrophobic components in the hydrogel insert into the lipid domains of the bacterial membrane, forming pores and eventually lysing the bacteria. He predicts that microbes will "take a longer time, if at all, to develop resistance" to such hydrogels.
"The biodegradable antimicrobial hydrogels developed in this study offer an exciting opportunity for biofılm control," says chemical engineer Dacheng Ren from Syracuse University in Syracuse, N.Y. "The high activities of these gels in killing different microbes, gram-positive and gramnegative bacteria, and fungi, including multidrug-resistant strains, are very
MINITOPIC

Policy Specifies More Oversight for Dual Use Research
The Obama Administration in February issued its new policy for conducting additional reviews of "dual use research of concern (DURC)"-that is, a framework that took shape through a response to specific experiments involving "gain of function" experiments modifying highly pathogenic H5N1 influenza viruses (Microbe, March 2013, p. 107 , and see p. 200 of this issue). This new framework, "United States Government Policy for Institutional Oversight of Life Sciences Dual Use Research of Concern," requires universities and similar institutions receiving federal support for research to "review their current life sciences research involving those pathogens or toxins deemed to be the most dangerous or most amenable to misuse, and then work with the researchers and funding agencies to develop appropriate risk mitigation plans." This requirement adds to earlier steps taken by federal agencies to conduct their own extra reviews of pending and funded research proposals involving DURC. The Department of Health and Human Services is the lead federal agency for this policy, which was developed in the Office of Science and Technology Policy. 
RESEARCH ADVANCES
Mutation Enables Flu Change in Hosts, Leads to Safety Look David C. Holzman
A single mutation in the H5N1 avian influenza virus that changes the pH at which the hemagglutinin surface protein is activated and simultaneously lowers its capacity to infect ducks while raising its capacity to infect mammals, according to Charles J. Russell of St. Jude Children's Research Hospital in Memphis, Tenn., and his collaborators. Because the research appeared possibly to meet the federal defınition for "dual use research of concern" (DURC), it drew special attention from ASM reviewers and editors, and was subject to special scrutiny, according to Thomas Shenk of Princeton University in Princeton, N.J., who chairs the ASM Publications Board.
Following careful deliberations, however, the research was deemed fıt to publish, according to Terence S. Dermody of Vanderbilt University in Nashville, Tenn., who is an editor of the Journal of Virology, where that research is published in February 2013 (doi:10.1128/JVI.03110-12). "These data contribute new information about viral determinants of influenza virus virulence and provide additional evidence to support the idea that H5N1 influenza virus pathogenesis in birds and mammals is linked to the pH of [hemagglutinin] activation in an opposing fashion," he notes in an editorial accompanying the paper from Russell and his collaborators. However, Dermody says, "The addition of the key mutation in the Russell paper to other previously reported mutations would not result in an even more virulent H5N1 influenza virus." Thus, the research does not fulfıll a key part of the defınition for DURC.
When influenza viruses infect birds, low pH activates the viral hemagglutinin surface protein, enabling the virus to invade cells. A mutant version of the influenza H5N1 virus called K58I resists acid activation and thus loses its capacity to infect ducks, according to Russell. However, that mutation renders the hemagglutinin protein resistant to acid, making the virus more infective in mice.
Indeed, the K58I mutant virus grows 100-fold better than the wildtype in the nasal cavities of mice, and is 50% more lethal to the animals. Conversely, K58I fails to kill ducks, whereas the wild-type virus kills 66% of them, Russell says. "A single mutation that eliminates H5N1 growth in ducks simultaneously enhances the capacity of H5N1 to grow in mice. We conclude that enhanced resistance to acid inactivation helps adapt H5N1 influenza virus from an avian to a mammalian host."
Various influenza viruses spread among wild birds, but few gain the capacity to infect humans. However, once they can spread effıciently from person to person, they sometimes cause global epidemics, such as the pandemic of 1918, during which influenza and ensuing complications killed an estimated 2.7% of the human population. Some flu viruses are exceptionally lethal for, albeit poorly transmitted among, humans. The H5N1 strain, for example, appears to kill more than half the humans it infects.
Reviewers of manuscripts submitted to ASM journals are required to flag them when appropriate for potential DURC, and journal editors monitor these efforts, according to Shenk. Flagged manuscripts then are forwarded to the journal's editor-in-chief, who notifıes Shenk. He and a special group of editors of ASM journals then evaluate such manuscripts. "In addition, all accepted manuscripts report-
MINITOPIC
Glimpses in General and Two Specific Antimicrobial Mechanisms
Here is a look at antimicrobial mechanisms in general and at two antimicrobial agents in particular:
• ing work with select agents are subject to a fınal review by the editor-in-chief and the chair of the Journals Board," he says.
David Holzman is the Microbe Journal Highlights Editor.
RESEARCH ADVANCES
Molecular Clock Lets Influenza A Evade Host Immune Response Carol Potera
The nuclear export protein (NEP) of influenza A determines when the replicated virus exits from the nuclei of host cells, thus acting as a molecular clock while also controlling the spread of this virus, according to Benjamin tenOever at the Icahn School of Medicine at Mount Sinai in New York, N.Y., and his collaborators. If too much NEP is made too quickly, the virus cannot multiply effıciently. However, if NEP is produced too slowly, the host immune system has a better chance at neutralizing the lingering virus. Details appear in the January 15, 2013 Cell Reports (doi:10.1016/j.celrep.2012.12.010).
"NEP is a long-forgotten component of influenza A," says tenOever, noting that few laboratories bother to study this protein or what it does. Research on another minor protein of this virus, NS1, which is produced alongside NEP, helped to kindle tenOever's interest in NEP. After fınding that NS1 blocks the host cell response to the virus, he and his collaborators engineered a strain to stop making that protein. However, instead of becoming attenuated, that strain remains virulent. This surprising and frustrating result prompted them to think again about the role of NEP.
After influenza A enters a cell, NS1 and NEP are both made, but the latter accumulates more slowly due to an ineffıcient splice site. Ordinarily, influenza A takes 8 h to replicate in the nucleus and then spread to other cells before triggering any response from the immune system. In effect, the slower accumulation of NEP acts as an internal clock, determining how long the virus remains safe from the immune system within human cells, according to tenOever. "That's how the timer works," he says.
The research group at Mount Sinai manipulated the ineffıcient splice site and used microRNAs to produce influenza A strains that produce either high levels of NS1 and low levels of NEP, or low levels of NS1 and high levels of NEP, tenOever continues. When NEP levels are high, the virus buds too early and cannot make other viral components. Meanwhile, when NEP levels are low, the virus remains in the nucleus for up to 12 h, making it vulnerable to the immune system.
NEP might serve as a target for treating influenza infections, according to tenOever. Molecules that bind NEP to slow the clock may "give your immune system time to neutralize the virus and make antibodies to it for life," he says. Alternatively, attenuating that clock could lead to a novel class of vaccines.
However, the high mutation rate for influenza makes "one wonder how long it would take the virus to reset its clock," says virologist Ervin Fodor at the University of Oxford in Oxford, United Kingdom. Such a reset likely would undermine the advantages of that vaccine design approach. Nonetheless, he adds, these overall fınd-ings are "another great example of the ingenious mechanisms that exist in viruses."
Carol Potera is a freelance writer in Great Falls, Mont.
RESEARCH ADVANCES
Newly Recognized Phage Quartet Infect "Most Successful" Marine Bacteria Marcia Stone
Four recently identifıed Sargasso 11 (SAR11) pelagiphages, DNA viruses, named for the Candidatus Pelagibacter ubique that they infect, offer proof that these most successful marine bacteria are not immune to viral predation, according to Stephen J. Giovannoni at Oregon State University (OSU) in Corvallis and his collaborators there and elsewhere. Details appear in the February 13, 2013 Nature (doi:10.1038 .nature11921).
The newly described viral predators help resolve a longstanding debate about why SAR11 bacteria dominate the ocean ecosystem, according to Giovannoni. "The abundance of P. ubique, which comprise about onethird of the bacteria in our planet's oceans, is probably the result of a suc-
MINITOPIC
CDC Urges Actions To Curb Drug-Resistant Enterobacteriaceae
Officials of the Centers for Disease Control and Prevention (CDC) in Atlanta, Ga., in March called for actions to halt the fast-rising spread of carbapenem-resistant enterobacteriaceae (CRE).
Although not yet common nationally, the percentage of Enterobacteriaceae that are CRE increased fourfold in the past decade. Moreover, one pathogen within this group, CRE Klebsiella pneumoniae, increased sevenfold during that period. "Doctors, hospital leaders, and public health, must work together now to implement the CDC detect and protect strategy to stop these infections from spreading," says CDC Director Tom Frieden. In a separate study, Ritu Banerjee of the Mayo Clinic in Rochester, Minn., and collaborators point to antibiotic-resistant Escherichia coli sequence type ST131 as increasing sharply among older adults and residents of nursing homes. Details appear in the April 2013 Infection Control and Hospital Epidemiology (34:361-369).
Microbe-Volume 8, Number 5, 2013 • 201 cessfully evolved adaption to resource competition rather than its talents as a slow-growing 'defense specialist' against bacteriophage," he says. Moreover, these pelagiphages, especially the widely distributed HTVC010P, place podoviruses among the most prolifıc virus subfamilies in the biosphere.
Pelagiphages HTVC011P and HTVC019P belong to the short-tailed Podoviridae family, according to project leader Yanlin Zhao, also from OSU. Another podovirus, HTVC010P, is not yet classifıed, and HTVC008M resembles T4-like myoviruses, he says.
Genome sequence data and morphology indicate that pelagiphages are related to the viruses that prey on cyanobacteria, according to Zhao. This and other fındings suggest that SAR11 arose in an environment where phage predation was common, he says. "Indeed, the pelagiphages and SAR11 seem to be a good example of a highly coevolved host-virus system developed over billions of years," agrees Curtis Suttle at the University of British Columbia in Vancouver, Canada.
Superior competitiveness for nutrients made SAR11 the dominant bacteria of oceans, and their abundance protected them against viral decimation, Giovannoni says, explaining how the "kill-the-winner" hypothesis fails in this instance. "Population density may increase encounter rates with infective phage particles, but it also means that that SAR11 DNA has greater opportunity for recombination by conjugation and transformation. Previous research has reported recombination rates in SAR11 populations among the highest on record. Our research documents these fınding and also shows that these high recombination rates, particularly in the hypervariable regions, enable a rapid adaption to novel phage phenotypes."
That SAR11 and pelagiphage coevolve fıts with the Red Queen Hypothesis, which holds that species have to "run" to stay in place, and helps to explain the seeming paradox that these bacteria are both abundant and phage susceptible. In contrast, the relationship between SAR11 and pelagiphages appears to conflict with the Kill-theWinner hypothesis, Giovannoni says.
"The discovery of SAR11 viruses, although not unexpected, is a notable advance in the understanding of the most abundant bacteria and viruses in the oceans," says David L. Kirchman from the University of Delaware in Lewes. However, SAR11 could still be a defense specialist, albeit an imperfect one, especially if it grows slowly in the wild. He contends that a slowgrowing defense specialist, no matter how abundant, would invariably take second place biogeochemically to faster-growing competitors. "The Giovannoni group's report answers a lot of The world's oceans are home to some of the most abundant organisms in the biosphere, such as the recently characterized microbe Candidatus Pelagibacter ubique, which comprise about a third of the bacteria in the oceans. Researchers now find that these bacteria are subject to predation by phages, the SAR11 pelagiphages, raising questions about how marine viruses control bacterial populations. (Image © Dean Turner/iStockphoto.)
MINITOPIC
NASA Says Mars Rocks Contain What Microbes Need for Life
Scientists at NASA say that the chemical composition at some sites now being explored on Mars appear suitable for supporting microorganisms, based on analysis coming back from Curiosity, the mobile instrument package that was landed on the planet last August. The instrument drilled powder from sedimentary rock situated in an area called the Yellowknife Bay, and the sample contains sulfur, nitrogen, hydrogen, oxygen, phosphorous, and carbon, according to lead scientist Michael Meyer of the NASA Mars Exploration Program in Pasadena, Calif. The chemical ingredients in the sample are "impressive, and it suggests pairings such as sulfates and sulfides that indicate a possible chemical energy source for microorganisms," adds Paul Mahaffy, principal investigator of the sample analysis instruments at the Goddard Space Flight Center in Greenbelt, Md. Other NASA scientists describe this area of Mars as being "the end of an ancient river system or an intermittently wet lake bed,"-now dry-that "was not harshly oxidizing, acidic, or extremely salty." questions but also prompts new ones about marine viruses and their control of ocean microbes," he says. Another potential advantage to TIPs is their ability to mutate along with HIV. "HIV rapid mutation leads to resistance against antiretorivirals and poses signifıcant challenges for vaccine development," Weinberger says. "But TIPs replicate with the same speed and mutational rate as the pathogen, which sets up an evolutionary arms race."
Addressing ethical concerns about TIPs being transmitted to some individuals without their direct consent, Weinberger and Torbett cite the oral polio vaccine. "A recognized advantage of the oral polio vaccine is that it replicates in vivo and sheds, thereby transmitting among susceptible hosts and delivering additional protections via 'transmissible immunization' at the population scale," says Weinberger. TIPs, however, can be transmitted only within the HIV-infected population.
Weinberger and Torbett, noting that the TIPs idea is controversial and their fındings preliminary, remain optimistic about its potential. "TIPS may offer a unique strategy for targeting both high-risk and hard-to-reach populations, especially in resource-limited settings," Weinberger says. "Thus, the TIP concept may apply broadly to other viral infectious diseases and would represent a new paradigm for disease control, away from pathogen eradication but towards robust disease suppression."
"Their sophisticated, highly theoretical, computational analysis of HIV and TIP-infected human populations support the possibility of using such particles to exert partial control over the seriousness as well as the spread of AIDS, especially among high-risk populations," says virologist Alice Huang of the California Institute of Technology in Pasadena, referring to Weinberger and Torbett. "Some recent progress on influenza virus with laboratory infections as well as animals indicate the feasibility of using genetically engineered mutants for controlling or ameliorating influenza infections," she adds, alluding in more general terms to this approach. Although considerable more research is required, she is convinced that these tactics will eventually pay off for controlling viral diseases such as AIDS and flu.
